Replies to post #62105 on Biotech Values

[DewDiligence]

Copaxone – After adjusting for growth attributable to pricing and currency, the growth in unit volume looks impressive in its own right. We don’t have the info to calculate the exact figure, but we’ll get it on Teva’s CC.